Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Deal Watch: Roche Aborts But Regeneron, Amgen and Pfizer Sign Up

Executive Summary

Deal activity over the past seven days sees Roche knock back Inovio a second time, Regeneron plan for its future via an alliance with Adicet Bio, Amgen supplement its preclinical pipeline with a candidate from Advaxis, and Pfizer shore up its gene therapy ambitions with an acquisition.


Related Content

CHA, Sorrento JV Highlights Korean Immuno-Oncology Appetite
Astellas Dips Into Digital Health Via New Venture
Filings Soon As Biogen Snaps Up Ionis' Antisense Treatment
Teva Embarks On New Phase With FTC Clearance Of Allergan Generics
Mayne Cements Place On US Generics Map
Kite Founder Jakobovits Raises $51m For Off-The-Shelf Startup Adicet; Aprecia Prints $35m
Cellectis Success With Off-The-Shelf CAR-T Threatens Kite, Juno, Novartis
Advaxis Sinks On Delayed Disclosure Of Clinical Hold
Inovio surprised by Roche returning prostate cancer immunotherapy
Roche licenses two of Inovio's early-stage DNA vaccines


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts